Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
185 participants
OBSERVATIONAL
2013-01-01
2021-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tumor Classification and Its Application in Surgical Treatment of Craniopharyngioma
NCT00949156
1.5T Intraoperative MR Imaging in Craniopharyngiomas
NCT01206543
Evaluation of Acupuncture Effects for Complications After Surgery of Cerebellopontine Angle Tumor in Skull Base
NCT04249921
Weight Gain in Surgically Treated Adult-onset Craniopharyngioma
NCT01968603
Sphenoorbital Meningioma Management.
NCT04710485
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non-hemorrhage group
Patients recognized as craniopharyngioma pathologically without tumoral hemorrhage observed during the operation
No interventions assigned to this group
Hemorrhage group
Patients recognized as craniopharyngioma pathologically with tumoral hemorrhage observed during the operation
intratumoral hemorrhage
Patients who were recognized as craniopharyngioma pathologically with tumoral hemorrhage observed during the operation were enrolled in the hemorrhage group.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
intratumoral hemorrhage
Patients who were recognized as craniopharyngioma pathologically with tumoral hemorrhage observed during the operation were enrolled in the hemorrhage group.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* enter our hospital between January 2013 and February 2021
Exclusion Criteria
* have received surgical or radiological treatment on the sellar region
* receive treatment of coagulation modulation, immunosuppressive agents or chemotherapeutic drugs
* combine with other clinical emergencies including acute myocardial infarction, cerebral stroke, trauma and sepsis at admission
* have been diagnosed with other tumors, hematological diseases, autoimmune diseases, liver failure or renal failure
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tongji Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kai Shu
Prof. Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kai Shu, MD
Role: STUDY_DIRECTOR
Tongji Hospital
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
kaishu1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.